Abbott India Share Price

₹ 25,895.00

+₹260.00 (1.01%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: ABBOTINDIA
|
Pharmaceuticals

Abbott India Share Price Today

As of 3 Nov 2026, Abbott India share price is ₹25,895.00. The stock opened at ₹25,850.00, compared to its previous close of ₹25,635.00. During today's trading session, Abbott India share price moved in the range of ₹25,630.00 to ₹25,930.00, with an average price of ₹25,780.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹24,650.00 and a high of ₹30,655.00. On the performance front, Abbott India share price has increased by 1.51% over the last six months and is down 10.95% on a year-on-year basis.

Share price over the last 1 day rose from 25635.00 to 25895.00, ranging between 25635.00 and 25925.00.
₹25,630.00
1.01% up today
₹25,930.00
1D LOW
1D HIGH

Abbott India Stock Insights

Stock Performance
OutperformingBeat Nifty by 5.29 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 7.41%
Shareholding Pattern
FIIFII increased stake by 4.27%
Technical Indicators
Volume SpikeVolume is 58.0% above 20-day average on 1 Day interval.
Abbott India stock performance
Open₹25,850.00
High₹25,930.00
Low₹25,630.00
Prev. close₹25,635.00
Abbott India trading activity
Volume5,062
Average traded price₹25,795.69
Last traded time03:29:49 02 Nov
Last traded quantity1
Circuit
L
H
₹20,510.00
₹30,760.00
52-week
L
H
₹24,650.00
₹30,655.00
Mkt Cap Cr
54,385.76
P/E
33.68
P/B
11.39
ROA
33.03%
ROE
37.86%
ROCE
54.9%
Quick Ratio
1.91
EV/EBITDA
23.19

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Abbott India has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Abbott India appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Abbott India Company Background

ISIN
INE358A01014
Sector Market Cap
₹ 54,385.76 Cr

Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.

Abbott India Financial Highlights

  • Revenue: Abbott India reported revenue of ₹7,217.19 crore in FY26 vs ₹6,684.73 crore in FY25. It showed an increase of 7.97% on a yearly basis.
  • Operating Profit: Abbott India reported an operating profit of ₹2,079.27 crore in FY26 vs ₹1,886.95 crore in FY25. It showed an increase of 10.19% on a year-on-year basis.
  • Net Profit: Abbott India reported a net profit of ₹1,552.02 crore in FY26 vs ₹1,414.44 crore in FY25. It showed an increase of 9.73% on a yearly basis.

Abbott India Quarterly Result Highlights

  • Abbott India reported revenue of ₹1,889.05 crore in Jun 2026, compared with ₹1,785.10 crore in Mar 2026, representing an increase of 5.82% on a quarter-on-quarter (QoQ) basis.
  • Abbott India reported an operating profit of ₹572.21 crore in Jun 2026, compared with ₹531.23 crore in Mar 2026, representing an increase of 7.71% on a quarter-on-quarter (QoQ) basis.
  • Abbott India reported a profit of ₹428.52 crore in Jun 2026, compared with ₹394.93 crore in Mar 2026, reflecting an increase of 8.51% on a QoQ basis.
  • The earnings per share (EPS) of Abbott India stood at ₹730.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
74.99%
FII
0.40%
Other DII
1.44%
Retail and other
15.63%
Mutual funds
7.55%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.18%
Mar 20260.26%
Jun 20260.38%
Sep 20260.40%

Abbott India Investment Returns

1 day
+0.72%
1 week
+2.36%
1 month
-3.80%
1 year
-10.95%
3 years
+15.36%
5 years
+27.14%

Abbott India Share Price History

Abbott India share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹25,850.00 / ₹25,895.00
+1.01%
30 Oct 26
₹26,005.00 / ₹25,635.00
-1.95%
29 Oct 26
₹26,380.00 / ₹26,145.00
-0.49%
28 Oct 26
₹25,515.00 / ₹26,275.00
+2.98%
Show more

Abbott India Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,929.05₹6,409.15₹5,848.91₹5,348.73
Other Income₹288.14₹275.58₹248.27₹154.15
Total Revenue₹7,217.19₹6,684.73₹6,097.18₹5,502.88
Total Expenses₹5,137.92₹4,797.78₹4,479.43₹4,229.06
Profit Before Tax₹2,079.27₹1,886.95₹1,617.75₹1,273.82
Tax₹527.25₹472.51₹416.53₹324.41
Profit After Tax₹1,552.02₹1,414.44₹1,201.22₹949.41
EPS - Basic₹730.36₹665.62₹565.28₹446.80
EPS - Diluted₹730.36₹665.62₹565.28₹446.80

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,079.27₹1,886.95₹1,617.75₹1,273.82
Income before WC changes₹1,929.42₹1,715.60₹1,487.90₹1,211.12
Change in Assets-₹123.76-₹310.61₹18.74₹27.19
Change in Liabilities₹53.27₹53.91₹110.64-₹4.06
Change in WC-₹70.49-₹256.70₹129.38₹23.13
Cash flow from Operations₹1,319.24₹1,011.84₹1,212.81₹893.39
Cash flow from Investing-₹371.38₹182.18-₹416.03-₹147.71
Cash flow from Financing-₹1,066.12-₹925.17-₹744.71-₹638.72
Total Cash Flow-₹118.26₹268.85₹52.07₹106.96
Cash (Start of the year)₹560.59₹291.74₹239.67₹132.71
Cash (End of the year)₹442.33₹560.59₹291.74₹239.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,731.24₹1,153.92₹1,947.65₹1,530.40
Current Assets₹3,770.69₹4,763.39₹3,245.84₹3,025.11
Total Assets₹6,501.93₹5,917.31₹5,193.49₹4,555.51
Current Liabilities₹1,476.57₹1,407.19₹1,342.72₹1,206.02
Net Current Asset₹2,294.12₹3,356.20₹1,903.12₹1,819.09
Non-Current Liabilities₹251.17₹276.97₹151.88₹160.95
Equity Capital₹4,774.19₹4,233.15₹3,698.89₹3,188.54
Total Equity & Liabilities₹6,501.93₹5,917.31₹5,193.49₹4,555.51
* All values are in INR Crore
Abbott India market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Abbott India technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.54
Neutral
ATR (14)
612.14
Neutral
STOCH(9,6)
53.39
Neutral
STOCH RSI (14)
56.93
Neutral
ADX(9)
23.52
Bearish
UO(9)
49.34
Neutral
ROC(12)
-0.23
Bearish
WillR(14)
-48.16
Neutral
Period
Simple value
Exponential vaue
5D
25759
25785.71
10D
25694
25782.28
20D
25883
25910.08
50D
26148
26217.05
100D
26584.5
26414.97
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Abbott India
Pharmaceuticals
Add Stock
Add Another

Abbott India Returns Calculator

Ex-date: 24 Jul 2026
Ex-date: 24 Jul 2026

Abbott India Latest News

1 month ago
Mankind, Dr Reddy, Gland Pharma, others lift Nifty Pharma up over 1% as US exempts certain drugs from 100% tariffs
3 months ago
Dividends, bonus issues, stock splits this week: Bharti Airtel, Hero MotoCorp, Info Edge, Pidilite, Divi's Labs, Abbott India, others in focus
5 months ago
Q4 results: Canara Bank, JSW Energy, Indian Hotels Company, UPL, Abbott India, PVR Inox, others to post earnings on May 11
Showing news item 1 of 3

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Abbott India Share Price FAQs

Please be aware that Abbott India stock prices are subject to continuous fluctuations due to various factors.